Literature DB >> 19564724

Are the effects of isoniazid preventive therapy and highly active antiretroviral therapy additive in preventing HIV-associated tuberculosis?

Robin Wood, Stephen D Lawn, Linda-Gail Bekker.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19564724      PMCID： PMC3801092          DOI： 10.1097/QAD.0b013e32832d53e7

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  7 in total

1.  Tuberculosis among HIV-infected patients receiving HAART: long term incidence and risk factors in a South African cohort.

Authors:  Stephen D Lawn; Motasim Badri; Robin Wood
Journal:  AIDS       Date:  2005-12-02       Impact factor: 4.177

2.  Isoniazid prophylaxis for tuberculosis in HIV infection: a meta-analysis of randomized controlled trials.

Authors:  H C Bucher; L E Griffith; G H Guyatt; P Sudre; M Naef; P Sendi; M Battegay
Journal:  AIDS       Date:  1999-03-11       Impact factor: 4.177

3.  Burden of tuberculosis in an antiretroviral treatment programme in sub-Saharan Africa: impact on treatment outcomes and implications for tuberculosis control.

Authors:  Stephen D Lawn; Landon Myer; Linda-Gail Bekker; Robin Wood
Journal:  AIDS       Date:  2006-08-01       Impact factor: 4.177

Review 4.  Treatment of latent tuberculosis infection in HIV infected persons.

Authors:  S Woldehanna; J Volmink
Journal:  Cochrane Database Syst Rev       Date:  2004

5.  Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study.

Authors:  Motasim Badri; Douglas Wilson; Robin Wood
Journal:  Lancet       Date:  2002-06-15       Impact factor: 79.321

6.  The impact of antiretroviral therapy and isoniazid preventive therapy on tuberculosis incidence in HIV-infected patients in Rio de Janeiro, Brazil.

Authors:  Jonathan E Golub; Valeria Saraceni; Solange C Cavalcante; Antonio G Pacheco; Lawrence H Moulton; Bonnie S King; Anne Efron; Richard D Moore; Richard E Chaisson; Betina Durovni
Journal:  AIDS       Date:  2007-07-11       Impact factor: 4.177

7.  Isoniazid preventive therapy, HAART and tuberculosis risk in HIV-infected adults in South Africa: a prospective cohort.

Authors:  Jonathan E Golub; Paul Pronyk; Lerato Mohapi; Nkeko Thsabangu; Mosa Moshabela; Helen Struthers; Glenda E Gray; James A McIntyre; Richard E Chaisson; Neil A Martinson
Journal:  AIDS       Date:  2009-03-13       Impact factor: 4.177
  7 in total
  2 in total

1.  Additive effects of isoniazid preventive therapy and HAART.

Authors:  Jonathan E Golub; Richard E Chaisson; Neil A Martinson
Journal:  AIDS       Date:  2009-07-17       Impact factor: 4.177

2.  Risk factors for increased immune reconstitution in response to Mycobacterium tuberculosis antigens in tuberculosis HIV-infected, antiretroviral-naïve patients.

Authors:  Tatiana Pereira da Silva; Carmem Beatriz Wagner Giacoia-Gripp; Carolina A Schmaltz; Flavia Marinho Sant'Anna; Maria Helena Saad; Juliana Arruda de Matos; Julio Castro Alves de Lima E Silva; Valeria Cavalcanti Rolla; Mariza Gonçalves Morgado
Journal:  BMC Infect Dis       Date:  2017-09-06       Impact factor: 3.090
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.